A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation

Overview of attention for article published in Frontiers in Cell and Developmental Biology, April 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 18 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,077 followers.

A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation https://t.co/Xxl0IrbUDB

12 May 2020

Reply Repost Favourite

A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation. #lymphoma #lymsm https://t.co/xxuFssOrcT

12 May 2020

Reply Repost Favourite

New article: A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation. https://t.co/hFybNDzHaY #DLBCL #lymsm #hematology

12 May 2020

Reply Repost Favourite

New Research: A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation: Diffuse large B cell lymphoma (DLBCL) is associated with aggressive clinical cases and poor prognosis despite recent advances in disease… https://t.co/wT

22 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.